Thermo Fisher Scientific, a global leader in scientific services, has announced plans to establish two new state-of-the-art facilities in Hyderabad's Genome Valley by the end of 2025. 

The investment is aimed at strengthening India's biopharma manufacturing infrastructure and expanding the company's presence in the country.

The two new centers will include a Bioprocess Design Centre and a Customer Experience Centre. 

The Bioprocess Design Centre is intended to serve as a hub for developing innovative bioprocessing workflows, while the Customer Experience Centre will provide hands-on demonstrations and training opportunities for customers. 

These facilities are part of Thermo Fisher's broader strategy to meet the increasing demand for biopharma solutions in India and support the growth of the life sciences market in the region.